Comparison of TNFα to Lipopolysaccharide as an Inflammagen to Characterize the Idiosyncratic Hepatotoxicity Potential of Drugs: Trovafloxacin as an Example
暂无分享,去创建一个
J. Waring | J. Luyendyk | E. Blomme | P. Ganey | R. Roth | L. Lehman-Mckeeman | M. Liguori | J. Maddox | D. Nelson | Amy C. Ditewig | Vasanthi M. Bhaskaran
[1] D. Adams,et al. Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.
[2] P. Ganey,et al. Intrinsic versus Idiosyncratic Drug-Induced Hepatotoxicity—Two Villains or One? , 2010, Journal of Pharmacology and Experimental Therapeutics.
[3] P. Ganey,et al. Trovafloxacin enhances TNF-induced inflammatory stress and cell death signaling and reduces TNF clearance in a murine model of idiosyncratic hepatotoxicity. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[4] A. D. Jones,et al. Sulindac Metabolism and Synergy with Tumor Necrosis Factor-α in a Drug-Inflammation Interaction Model of Idiosyncratic Liver Injury , 2009, Journal of Pharmacology and Experimental Therapeutics.
[5] J. Luyendyk,et al. Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models , 2009, Pharmacological Reviews.
[6] P. Ganey,et al. Trovafloxacin Enhances the Inflammatory Response to a Gram-Negative or a Gram-Positive Bacterial Stimulus, Resulting in Neutrophil-Dependent Liver Injury in Mice , 2009, Journal of Pharmacology and Experimental Therapeutics.
[7] J. Waring,et al. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. , 2009, Toxicology letters.
[8] P. Muriel. NF‐κB in liver diseases: a target for drug therapy , 2009, Journal of applied toxicology : JAT.
[9] P. Ganey,et al. Tumor Necrosis Factorα Is a Proximal Mediator of Synergistic Hepatotoxicity from Trovafloxacin/Lipopolysaccharide Coexposure , 2009, Journal of Pharmacology and Experimental Therapeutics.
[10] J. Waring,et al. Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[11] C. de Castro,et al. Lipopolysaccharide structures from Agrobacterium and Rhizobiaceae species. , 2008, Carbohydrate research.
[12] Philip R. Cohen,et al. TPL2-mediated activation of ERK1 and ERK2 regulates the processing of pre-TNFα in LPS-stimulated macrophages , 2008, Journal of Cell Science.
[13] J. Bradley,et al. TNF‐mediated inflammatory disease , 2008, The Journal of pathology.
[14] P. Ganey,et al. Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[15] J. Mitchell,et al. Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. , 2007, The Journal of endocrinology.
[16] M. Lennartz,et al. Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro. , 2006, Microbial pathogenesis.
[17] Michael J Liguori,et al. Modest Inflammation Enhances Diclofenac Hepatotoxicity in Rats: Role of Neutrophils and Bacterial Translocation , 2006, Journal of Pharmacology and Experimental Therapeutics.
[18] Michael J Liguori,et al. Investigations toward enhanced understanding of hepatic idiosyncratic drug reactions , 2006, Expert opinion on drug metabolism & toxicology.
[19] L. O’Neill,et al. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. , 2006, Biochemical pharmacology.
[20] R. Snyder,et al. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. , 2006, Pharmacogenomics.
[21] G. Ruthel,et al. Anthrax Lethal Toxin Impairs Innate Immune Functions of Alveolar Macrophages and Facilitates Bacillus anthracis Survival , 2006, Infection and Immunity.
[22] J. Luyendyk,et al. Unique gene expression and hepatocellular injury in the lipopolysaccharide-ranitidine drug idiosyncrasy rat model: comparison with famotidine. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[23] J. Waring,et al. Microarray Analysis of Lipopolysaccharide Potentiation of Trovafloxacin-Induced Liver Injury in Rats Suggests a Role for Proinflammatory Chemokines and Neutrophils , 2006, Journal of Pharmacology and Experimental Therapeutics.
[24] Zhijian J. Chen,et al. TRAF2: A Double-Edged Sword? , 2005, Science's STKE.
[25] B. Pulendran. Modulating vaccine responses with dendritic cells and Toll‐like receptors , 2004, Immunological reviews.
[26] J. Luyendyk,et al. Ranitidine Treatment during a Modest Inflammatory Response Precipitates Idiosyncrasy-Like Liver Injury in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.
[27] S. Janssens,et al. Role of Toll-Like Receptors in Pathogen Recognition , 2003, Clinical Microbiology Reviews.
[28] R. Stahlmann. Clinical toxicological aspects of fluoroquinolones. , 2002, Toxicology letters.
[29] S. Bursian,et al. Underlying endotoxemia augments toxic responses to chlorpromazine: is there a relationship to drug idiosyncrasy? , 2002, The Journal of pharmacology and experimental therapeutics.
[30] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[31] P. Libby,et al. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. , 1999, The Journal of clinical investigation.
[32] P. Nettesheim,et al. Tumor necrosis factor-alpha modulates the expression of its p60 receptor and several cytokines in rat tracheal epithelial cells. , 1996, Journal of immunology.
[33] D. Kufe,et al. Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. , 1990, Cancer research.
[34] J Horiguchi,et al. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.